Versant Capital Management’s Cadence Bank CADE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,860
Closed -$79.7K 2791
2025
Q4
$79.7K Sell
1,860
-9
-0.5% -$357 0.01% 862
2025
Q3
$70.2K Hold
1,869
0.01% 869
2025
Q2
$59.8K Sell
1,869
-210
-10% -$6.29K 0.01% 890
2025
Q1
$63.1K Buy
2,079
+1,059
+104% +$35.1K 0.01% 778
2024
Q4
$35.1K Buy
1,020
+224
+28% +$7.88K 0.01% 730
2024
Q3
$25.4K Hold
796
0.01% 725
2024
Q2
$22.5K Hold
796
0.01% 672
2024
Q1
$23.1K Hold
796
0.01% 463
2023
Q4
$23.6K Hold
796
0.01% 430
2023
Q3
$16.9K Hold
796
0.01% 536
2023
Q2
$15.6K Sell
796
-8
-1% -$158 0.01% 599
2023
Q1
$16.7K Sell
804
-27
-3% -$672 0.01% 554
2022
Q4
$20.5K Hold
831
0.01% 442
2022
Q3
$21K Hold
831
0.01% 406
2022
Q2
$20K Hold
831
0.01% 428
2022
Q1
$24K Sell
831
-568
-41% -$17.7K 0.01% 420
2021
Q4
$42K Buy
+1,399
New +$42.3K 0.01% 280
2016
Q4
Sell
-16
Closed 1394
2016
Q3
$0 Hold
16
﹤0.01% 1380
2016
Q2
$0 Hold
16
﹤0.01% 1345
2016
Q1
$0 Hold
16
﹤0.01% 1339
2015
Q4
$0 Buy
+16
New +$401 ﹤0.01% 1342

Other funds holding CADE

Versant Capital Management's CADE Position: Q1 2026 in Review

Versant Capital Management sold out of Cadence Bank (CADE) in Q1 2026, closing a stake of 1,860 shares — an estimated $79.7K sold.

Versant Capital Management first reported a position in CADE in Q4 2015 and held it in 21 quarters. The position peaked at $79.7K in Q4 2025. 2 funds tracked by Wall St. Rank hold CADE as of Q1 2026.

  • Versant Capital Management reported no remaining Cadence Bank position as of Q1 2026 after selling out during the quarter.
  • Versant Capital Management sold 1,860 Cadence Bank shares in Q1 2026, an estimated $79.7K.
  • Versant Capital Management first reported a position in Cadence Bank in Q4 2015 and held it in 21 quarters.
  • Versant Capital Management's Cadence Bank position peaked at $79.7K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Cadence Bank as of Q1 2026.

Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.